173 filings
8-K
AGIO
Agios Pharmaceuticals Inc
28 May 24
Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
7:09am
8-K
AGIO
Agios Pharmaceuticals Inc
2 May 24
Agios Reports Business Highlights and First Quarter 2024 Financial Results
7:01am
8-K
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
8-K
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
AGIO
Agios Pharmaceuticals Inc
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am
8-K
knbxyys
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
8-K
x318p t8z8z
14 Jun 23
Departure of Directors or Certain Officers
4:05pm
8-K
kjfo2vw5j 7k
25 May 23
Departure of Directors or Certain Officers
4:02pm
8-K
nrimtvski
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
3g5 jx4ot6s7wb4h
19 Apr 23
Departure of Directors or Certain Officers
7:26am
8-K
bwn2 brjyravcnvrg
3 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
685te6q6l
23 Feb 23
Agios Reports Fourth Quarter and Full Year 2022 Financial Results
7:02am
8-K
ya1gn
9 Jan 23
Regulation FD Disclosure
7:18am
8-K
54lreah
16 Dec 22
Departure of Directors or Certain Officers
4:02pm
8-K
dw15c2hzfj zypgl
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
9d3c0 b3hk0u23
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
1z0u 8qc5f4
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
vgauyoqw7m3 qiffjo
7 Oct 22
Departure of Directors or Certain Officers
4:05pm
8-K
9ur6 rii799
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
sd15hg
7 Sep 22
Departure of Directors or Certain Officers
7:03am